Stock Research for VVUS

VVUS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VVUS Stock Chart & Research Data

The VVUS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VVUS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VVUS Due diligence Resources & Stock Charts

The VVUS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VVUS Detailed Price Forecast - CNN Money CNN View VVUS Detailed Summary - Google Finance
Yahoo View VVUS Detailed Summary - Yahoo! Finance Zacks View VVUS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View VVUS Trends & Analysis - Trade-Ideas Barrons View VVUS Major Holders - Barrons
NASDAQ View VVUS Call Transcripts - NASDAQ Seeking View VVUS Breaking News & Analysis - Seeking Alpha
Spotlight View VVUS Annual Report - CompanySpotlight.com OTC Report View VVUS OTC Short Report - OTCShortReport.com
TradeKing View VVUS Fundamentals - TradeKing Charts View VVUS SEC Filings - Bar Chart
WSJ View Historical Prices for VVUS - The WSJ Morningstar View Performance/Total Return for VVUS - Morningstar
MarketWatch View the Analyst Estimates for VVUS - MarketWatch CNBC View the Earnings History for VVUS - CNBC
StockMarketWatch View the VVUS Earnings - StockMarketWatch MacroAxis View VVUS Buy or Sell Recommendations - MacroAxis
Bullish View the VVUS Bullish Patterns - American Bulls Short Pains View VVUS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View VVUS Stock Mentions - StockTwits PennyStocks View VVUS Stock Mentions - PennyStockTweets
Twitter View VVUS Stock Mentions - Twitter Invest Hub View VVUS Investment Forum News - Investor Hub
Yahoo View VVUS Stock Mentions - Yahoo! Message Board Seeking Alpha View VVUS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for VVUS - SECform4.com Insider Cow View Insider Transactions for VVUS - Insider Cow
CNBC View VVUS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VVUS - OTC Markets
Yahoo View Insider Transactions for VVUS - Yahoo! Finance NASDAQ View Institutional Holdings for VVUS - NASDAQ


Stock Charts

FinViz View VVUS Stock Insight & Charts - FinViz.com StockCharts View VVUS Investment Charts - StockCharts.com
BarChart View VVUS Stock Overview & Charts - BarChart Trading View View VVUS User Generated Charts - Trading View




Latest Financial News for VVUS


Vivus stock rallies above $5 mark in volatile trade after reverse stock split takes effect
Posted on Tuesday September 11, 2018

Shares of Vivus Inc. rallied 6.6% to trade above the $5 mark in volatile morning trade Tuesday, after the biopharmaceutical company's 1-for-10 reverse stock split went into effect. The stock has been down as much as 12% at a split-adjusted intraday low of $4.15 and up as much as 18% at a high of $5.58 since the open. The stock had closed Monday at 47 cents on a pre-split basis. Vivus Chief Executive John Amos had said it enacted the split because it determined it would position the company with the "appropriate liquidity associated with listing shares on a major U.S. exchange," which Amos said was "critical" for the execution of its strategic plan to return to profitability. One of the Nasdaq's requirements for continued listing is a minimum bid price of $1 for a company's stock. Vivus shares have tumbled 43% over the past three months, while the iShares Nasdaq Biotechnology ETF has gained 6.4% and the S&P 500 has tacked on 3.4%.


New Growth Opportunities Jump for 3 Biotech Stocks in 2018
Posted on Tuesday September 11, 2018

CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Biotech stocks continue to present key drivers of returns for many investors. Public equities have delivered strong returns underpinned by large-scale of monetary policy support. It is particularly noteworthy that the California Public Employees' Retirement System is considering the creation of a direct investment program, which would include investment in companies within sectors like healthcare and biotechnology.


VIVUS Announces 1-for-10 Reverse Stock Split
Posted on Monday September 10, 2018

VIVUS, Inc. (VVUS) (the “Company”), a biopharmaceutical company, announced today that the Company’s stockholders approved a reverse stock split. Effective September 10, 2018, the Company will enact a 1-for-10 reverse stock split of its common stock with shares trading on a split-adjusted basis on September 11, 2018. “The 1-for-10 ratio was determined following an analysis of over 700 companies that effected a reverse split from 1998 to 2018.


Why Is Vivus (VVUS) Down 6.4% Since Last Earnings Report?
Posted on Thursday September 06, 2018

Vivus (VVUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.